| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -55,577 | 100% | $12.77 | -$709,811 |
| Net | -2 | -55,577 | -100% | -$709,811 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Quang X. Pham | CEO and Chairman, Director, 10%+ Owner | $5,583,285 | -$312,356 | -5.3% | 24 Oct 2025 |
| Lee Scott Golden | Director | $20,970 | 02 Dec 2025 | ||
| Matthew K. Szot | Chief Financial Officer | $0 | -$397,455 | -100% | 29 Dec 2025 |
| James J. Ferguson III | Chief Medical Officer | 05 Feb 2025 | |||
| John R. Murphy | Director | 23 Jan 2025 | |||
| DOUGLAS W. LOSORDO | Chief Medical Officer | 18 Jan 2024 | |||
| Dr. Glynn Wilson | Director | 23 Jan 2025 | |||
| Robert Lisicki | Director | 23 Jan 2025 | |||
| Steven Zelenkofske | Director | 23 Jan 2025 | |||
| Jeffrey Scott Cole | Chief Operating Officer | 23 Jan 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Matthew K. Szot | CVKD | Common Stock | Sale | -100% | $69,233 | $6.97 | -9,933 | 0 | 29 Dec 2025 | Direct |
| Lee Scott Golden | CVKD | Stock Options | Award | 5,000 | 5,000 | 02 Dec 2025 | Direct | |||
| Matthew K. Szot | CVKD | Common Stock | Sale | -15.3% | $25,182 | $13.99 | -1,800 | 9,933 | 27 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.67% | $18,397 | $13.99 | -1,315 | 196,089 | 27 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -13.3% | $25,182 | $13.99 | -1,800 | 11,733 | 24 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.57% | $15,840 | $14.03 | -1,129 | 197,404 | 24 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -11.7% | $25,326 | $14.07 | -1,800 | 13,533 | 13 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.9% | $25,470 | $14.15 | -1,800 | 198,533 | 13 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -9.94% | $23,685 | $13.99 | -1,693 | 15,333 | 09 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.89% | $25,236 | $14.02 | -1,800 | 200,333 | 09 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -0.62% | $1,497 | $13.99 | -107 | 17,026 | 06 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.25% | $7,065 | $14.13 | -500 | 202,133 | 02 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -9.03% | $23,783 | $13.99 | -1,700 | 17,133 | 01 Oct 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.43% | $12,343 | $14.01 | -881 | 202,633 | 01 Oct 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -0.53% | $1,400 | $14.00 | -100 | 18,833 | 29 Sep 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.21% | $5,870 | $14.01 | -419 | 203,514 | 29 Sep 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -36.5% | $153,182 | $14.05 | -10,900 | 18,933 | 25 Sep 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -3.22% | $95,671 | $14.09 | -6,790 | 203,933 | 25 Sep 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -4.79% | $20,993 | $14.00 | -1,500 | 29,833 | 24 Sep 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -1.21% | $36,108 | $13.99 | -2,581 | 210,723 | 24 Sep 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -1.26% | $5,600 | $14.00 | -400 | 31,333 | 28 Aug 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -0.56% | $16,690 | $13.99 | -1,193 | 213,304 | 28 Aug 2025 | Direct |
| Matthew K. Szot | CVKD | Common Stock | Sale | -4.8% | $22,392 | $14.00 | -1,600 | 31,733 | 27 Aug 2025 | Direct |
| Quang X. Pham | CVKD | Common Stock | Sale | -1.76% | $53,666 | $13.99 | -3,836 | 214,497 | 27 Aug 2025 | Direct |
| James J. Ferguson III | CVKD | Stock Options | Award | 60,000 | 60,000 | 05 Feb 2025 | Direct | |||
| Quang X. Pham | CVKD | Stock Options | Award | 65,000 | 65,000 | 23 Jan 2025 | Direct | |||
| JOHN RAYMOND MURPHY | CVKD | Stock Options | Award | 20,000 | 20,000 | 23 Jan 2025 | Direct | |||
| GLYNN WILSON | CVKD | Stock Options | Award | 20,000 | 20,000 | 23 Jan 2025 | Direct | |||
| Steven Zelenkofske | CVKD | Stock Options | Award | 20,000 | 20,000 | 23 Jan 2025 | Direct | |||
| Jeffrey Scott Cole | CVKD | Stock Options | Award | 25,000 | 25,000 | 23 Jan 2025 | Direct | |||
| Matthew K. Szot | CVKD | Stock Options | Award | 50,000 | 50,000 | 23 Jan 2025 | Direct | |||
| Robert Lisicki | CVKD | Stock Options | Award | 20,000 | 20,000 | 23 Jan 2025 | Direct | |||
| Quang X. Pham | CVKD | Common Stock | Gift | -1.5% | -50,000 | 3,275,000 | 10 Apr 2024 | Direct | ||
| Jeffrey Scott Cole | CVKD | Stock Options | Award | 150,000 | 150,000 | 02 Apr 2024 | Direct | |||
| Steven Zelenkofske | CVKD | Stock Options | Award | 100,000 | 100,000 | 18 Jan 2024 | Direct | |||
| JOHN RAYMOND MURPHY | CVKD | Stock Options | Award | 100,000 | 100,000 | 18 Jan 2024 | Direct | |||
| Robert Lisicki | CVKD | Stock Options | Award | 50,000 | 50,000 | 18 Jan 2024 | Direct | |||
| Quang X. Pham | CVKD | Stock Options | Award | 150,000 | 150,000 | 18 Jan 2024 | Direct | |||
| Matthew K. Szot | CVKD | Stock Options | Award | 250,000 | 250,000 | 18 Jan 2024 | Direct | |||
| GLYNN WILSON | CVKD | Stock Options | Award | 70,000 | 70,000 | 18 Jan 2024 | Direct | |||
| DOUGLAS W. LOSORDO | CVKD | Stock Options | Award | 150,000 | 150,000 | 18 Jan 2024 | Direct | |||
| Quang X. Pham | CVKD | Common Stock | Gift | -2.49% | -85,000 | 3,325,000 | 23 Oct 2023 | Direct | ||
| John R. Murphy | CVKD | Common Stock | Purchase | 0.44% | $1,842 | $0.6900 | 2,669 | 614,792 | 05 Oct 2023 | Direct |
| John R. Murphy | CVKD | Common Stock | Purchase | 2.91% | $12,132 | $0.7000 | 17,331 | 612,123 | 04 Oct 2023 | Direct |
| Quang X. Pham | CVKD | Common Stock | Purchase | 1.19% | $36,188 | $0.9047 | 40,000 | 3,410,000 | 05 Sep 2023 | Direct |
| Quang X. Pham | CVKD | Common Stock | Purchase | 2.12% | $63,945 | $0.9135 | 70,000 | 3,370,000 | 01 Sep 2023 | Direct |
| Robert Lisicki | CVKD | Stock options | Award | 75,000 | 75,000 | 23 Jul 2023 | Direct | |||
| John R. Murphy | CVKD | Common Stock | Purchase | 1.71% | $13,900 | $1.39 | 10,000 | 594,792 | 21 Mar 2023 | Direct |
| John R. Murphy | CVKD | Common Stock | Purchase | 3.6% | $33,398 | $1.67 | 20,000 | 574,792 | 16 Mar 2023 | Direct |
| Quang X. Pham | CVKD | Common Stock | Award | 0.76% | 25,000 | 3,300,000 | 10 Feb 2023 | Direct |